ACTAVIS LABS FL INC FDA Approval ANDA 075416

ANDA 075416

ACTAVIS LABS FL INC

FDA Drug Application

Application #075416

Documents

Review2014-08-01

Application Sponsors

ANDA 075416ACTAVIS LABS FL INC

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET, EXTENDED RELEASE;ORALEQ 500MG BASE0NAPROXEN SODIUMNAPROXEN SODIUM
002TABLET, EXTENDED RELEASE;ORALEQ 375MG BASE0NAPROXEN SODIUMNAPROXEN SODIUM
003TABLET, EXTENDED RELEASE;ORALEQ 750MG BASE0NAPROXEN SODIUMNAPROXEN SODIUM

FDA Submissions

ORIG1AP2002-08-27
LABELING; LabelingSUPPL2AP2003-04-23
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2003-04-23
LABELING; LabelingSUPPL6AP2007-04-03
LABELING; LabelingSUPPL8AP2008-02-21
LABELING; LabelingSUPPL12AP2015-04-15STANDARD
LABELING; LabelingSUPPL16AP2016-09-08STANDARD
LABELING; LabelingSUPPL19AP2019-11-25STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL12Null7
SUPPL16Null31
SUPPL19Null7

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

ACTAVIS LABS FL INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75416
            [companyName] => ACTAVIS LABS FL INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"NAPROXEN SODIUM","activeIngredients":"NAPROXEN SODIUM","strength":"EQ 500MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"NAPROXEN SODIUM","activeIngredients":"NAPROXEN SODIUM","strength":"EQ 375MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"NAPROXEN SODIUM","activeIngredients":"NAPROXEN SODIUM","strength":"EQ 750MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NAPROXEN SODIUM","submission":"NAPROXEN SODIUM","actionType":"EQ 500MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"NAPROXEN SODIUM","submission":"NAPROXEN SODIUM","actionType":"EQ 375MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"NAPROXEN SODIUM","submission":"NAPROXEN SODIUM","actionType":"EQ 750MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.